Job Purpose:

BTIG seeks a Managing Director to lead and grow the Healthcare Equity Capital Markets (“ECM”) franchise within the Investment Banking platform. This senior role is responsible for originating and executing equity financing transactions across the healthcare sector, delivering strategic capital markets advice to corporate clients, and deepening relationships with institutional investors. The ideal candidate is a proven revenue producer with strong market judgment, executive-level presence, and the ability to lead teams in a fast-paced, highly collaborative environment.

Duties & Responsibilities:

Source, develop, and maintain senior-level relationships with healthcare corporates, sponsors, and key ecosystem participants to drive new business.
Serve as a trusted advisor to C-suite executives and boards on equity financing strategy, market windows, investor positioning, and transaction structures.
Partner with sector and product leadership to build and execute annual business plans, revenue targets, and client coverage priorities.
Lead end-to-end execution of equity and equity-linked transactions including IPOs, follow-ons, confidentially marketed offerings, registered directs, PIPEs/private placements, at-the-market programs, and block trades (as applicable).
Oversee deal strategy, syndicate coordination, investor targeting, marketing approach, and pricing recommendations in partnership with Sales/Trading and Syndicate.
Ensure high-quality, accurate, and timely delivery of marketing and transaction materials (e.g., pitch decks, CIMs, investor presentations, management scripts).
Direct the development of sector and market content for corporate and institutional clients (market updates, relative value views, issuance trends, and positioning insights).
Use data-driven analytics to inform origination opportunities, client advice, and post-transaction follow-up.
Collaborate with Healthcare Investment Banking, Research, Sales & Trading, Corporate Access, and other product teams to maximize franchise impact and deliver a coordinated client experience.
Represent BTIG externally at conferences and industry events to strengthen brand visibility and client connectivity.
Lead, mentor, and develop junior bankers; set execution standards across modeling, materials, diligence support, and client communications.
Manage multiple live processes simultaneously while maintaining strong risk controls, compliance discipline, and attention to detail.

Requirements & Qualifications:

Must be based in (or willing to relocate to) the New York City area.
12+ years of relevant investment banking / ECM experience with significant healthcare transaction exposure; prior experience operating at senior coverage or ECM leadership level strongly preferred.
Demonstrated track record of origination and execution across healthcare equity financings (IPO and follow-on experience required; private placements preferred).
Strong client management skills with the ability to advise and influence senior executives.
Deep understanding of equity capital markets dynamics, investor behavior, and issuance processes.
Excellent analytical capabilities and strong command of financial statements/valuation; ability to guide (not necessarily produce) detailed modeling and analysis.
Outstanding written and verbal communication skills; strong presentation and storytelling ability.
Proven ability to lead teams, prioritize under pressure, and manage multiple concurrent transactions with precision.
High integrity and commitment to the highest ethical and compliance standards.
FINRA licenses

Important Notes:

Must be authorized to work full time in the U.S., BTIG does not offer sponsorship for work visas of any type
No phone calls please, the applicant will be contacted within two weeks if successful

About BTIG:

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 700 employees, BTIG, LLC and its affiliates operate out of 20 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities. The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status. BTIG is an equal opportunity employer Minorities/Females/People with Disabilities/Protected Veterans/Sexual Orientation/Gender Identity.

Compensation:

BTIG offers a competitive compensation and benefits package. Salary range is based on a variety of factors including, but not limited to, location, years of applicable experience, skills, qualifications, licensure and certifications, and other business and organization needs.
The current estimated base salary range for this role is $300,000.00 - $400,000.00 per year. Please note that certain positions are eligible for additional forms of compensation such as discretionary bonus or overtime.

Disclaimer: https://www.btig.com/disclaimer.aspx.

Estimated Salary Range: 300000.0 - 400000.0 USD

About the company

BTIG is a global financial services firm offering investment banking, institutional trading, research, and brokerage services to institutional and corporate clients. It provides strategic advisory and capital markets solutions, including prime brokerage and outsourced trading. It differentiates itself by delivering a broad, integrated set of services through a global network with direct market access. Its goal is to help clients meet tactical and transactional needs with advisory, execution, and financing capabilities.

Company Size

501-1,000

Company Stage

Acquired

Total Funding

$725M

Headquarters

San Francisco, California

Founded

2002

Get referred to BTIG

See people who can refer or advise you

Simplify's Take

What believers are saying

BTIG added Michael Bodino and Chris Gibson on July 8, 2026.
BTIG hired Tom Widener June 9, 2026, strengthening power and utilities coverage.
Brayden Mathews joined August 5, 2026, expanding franchise sales and corporate access.

What critics are saying

BTIG’s StoneX arbitration ended March 12, 2026, with punitive and injunction claims rejected.
U.S. Bancorp’s acquisition pressures BTIG to hit performance targets before 2029.
If rainmakers leave after integration, BTIG’s client franchise deteriorates quickly.

What makes BTIG unique

U.S. Bancorp kept BTIG as a separate broker-dealer on June 1, 2026.
BTIG pairs niche sector banking with trading, research, prime brokerage, and corporate access.
Recent hires in energy, utilities, metals, and derivatives broaden BTIG’s specialist coverage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options
Flexible Work Hours

Company News

Yahoo Finance

Aug 26th, 2026

BTIG appoints Mangesh Ghogre as managing director for metals and mining coverage

BTIG, a U.S. Bancorp company, has appointed Mangesh Ghogre as managing director within its Industrials Investment Banking group, focusing on metals and mining coverage. Ghogre brings over 20 years of global investment banking experience across the US and Asia. He previously served as managing director at ThinkEquity, providing equity capital markets coverage for US and Canadian metals, mining, and industrial companies. He also founded One Capita Advisors, offering capital raising and advisory services. Earlier in his career, Ghogre was regional head of equity capital markets at Nomura in Asia, leading IPOs, follow-on offerings, and block trades. He began his investment banking career in equity capital markets at HSBC in Asia.

Business Wire

Aug 26th, 2026

BTIG appoints Mangesh Ghogre as managing director for metals and mining coverage

BTIG, a U.S. Bancorp company, has appointed Mangesh Ghogre as Managing Director within its Industrials Investment Banking group, focusing on metals and mining coverage. Ghogre brings over 20 years of global investment banking experience across the US and Asia. He previously served as Managing Director at ThinkEquity, providing equity capital markets coverage for US and Canadian metals, mining, and industrial companies. He also founded One Capita Advisors and held senior positions at Nomura and HSBC in Asia. Jon Dever, Head of Investment Banking at U.S. Bancorp | BTIG, said Ghogre's deep knowledge of the metals and mining landscape will strengthen the firm's Industrials franchise.

Associated Press

Aug 5th, 2026

BTIG appoints Brayden Mathews as head of franchise sales following U.S. Bancorp acquisition

BTIG, a U.S. Bancorp company, has appointed Brayden Mathews as Head of Franchise Sales. In this role, he will also lead the firm's Specialty Sales and Corporate Access teams. Mathews brings over 20 years of experience in institutional equity sales and equity capital markets. He spent two decades at J.P. Morgan, most recently serving as the public side Head of ECM Distribution and previously leading the New York Equity Franchise Sales effort. BTIG's Franchise Sales group connects institutional investors with the firm's equity research, sector insights, and corporate access across US and global markets. The team works alongside research, trading, and investment banking to help clients translate analysis into investment ideas.

Business Wire

Aug 5th, 2026

U.S. Bancorp | BTIG announces Brayden Mathews as Head of Franchise Sales.

U.S. Bancorp | BTIG announces Brayden Mathews as Head of Franchise Sales. NEW YORK-(BUSINESS WIRE)-BTIG, a U.S. Bancorp company, announced today that Brayden Mathews has joined the firm as Head of Franchise Sales, where he will also lead BTIG's Specialty Sales and Corporate Access teams. "We are pleased to welcome Brayden to BTIG," said Chris Rollins, Co-Head of Securities at U.S. Bancorp | BTIG. "He brings a strong background in institutional equity franchise sales and equity capital markets, with an excellent track record of delivering market and transaction insight to clients. Brayden will be instrumental as we continue to build and enhance our Sales and Corporate Access platforms." Mr. Mathews has more than two decades of experience across institutional equity sales, equity capital markets, and technology-focused investing and research. He spent 20 years at J.P. Morgan, most recently as the public side Head of ECM Distribution, and previously led the New York Equity Franchise Sales effort. Mr. Mathews also served as an Analyst at Agnos Partners and an Associate Analyst at Fred Alger Management. Earlier in his career, he was an Equity Research Associate at UBS Investment Research, and an Equity Research Associate and Corporate Bond Product Manager at Salomon Smith Barney. BTIG's Franchise Sales group connects institutional investors with the firm's equity research, sector insights, and corporate access across U.S. and global markets. Working closely with research, trading, and investment banking, the team helps clients translate thematic and company-specific analysis into actionable conversations and investment ideas. The group supports tailored outreach, investor engagement, and ongoing coverage visibility. About U.S Bancorp | BTIG BTIG, a U.S. Bancorp company, is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. The firm's core capabilities include global execution, portfolio, electronic and outsource trading, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more. U.S. Bancorp acquired BTIG in 2026. Learn more. More News From BTIG NEW YORK-( BUSINESS WIRE )-BTIG announced today the appointment of Michael Bodino and Chris Gibson as Managing Directors within its Energy & Infrastructure Investment Banking group. These hires add senior expertise to the team and broaden the firm's coverage footprint."We are excited to welcome Michael and Chris to BTIG," said Jon Dever, Head of BTIG Investment Banking. "They bring complementary experience, deep industry knowledge, and strong client relationships that will further enhance ou... NEW YORK-( BUSINESS WIRE )-BTIG announced today the appointment of Tom Widener as Managing Director and Head of Power & Utilities within BTIG's Energy & Infrastructure Investment Banking group. Mr. Widener will play a key role in expanding BTIG's coverage across the power, utilities and broader energy infrastructure sectors, further strengthening the firm's capabilities in an increasingly active and evolving market. Mr. Widener brings more than 35 years of investment banking experience... NEW YORK-( BUSINESS WIRE )-BTIG announced today the appointment of Jason Rockland as a Managing Director and Yingkang Duan as a Director within the firm's Equity Derivatives Trading group. Mr. Duan and Mr. Rockland were hired to help expand BTIG's capabilities in risk-arbitrage volatility trading, a natural fit alongside the firm's Event Driven Trading business. "We are excited to welcome Jason and Yingkang to BTIG," said Anton LeRoy, Chief Executive Officer of BTIG. "Their deep experience in e... BTIG. Release Versions

Citybiz

Jul 28th, 2026

Aqtual appoints Daniil Kalyuzhny CFO to support clinical and commercial growth.

Aqtual appoints Daniil Kalyuzhny CFO to support clinical and commercial growth. July 28, 2026 Daniil Kalyuzhny Aqtual has appointed healthcare investment banking veteran Daniil Kalyuzhny as chief financial officer, strengthening its executive team as the precision medicine company advances its lead liquid biopsy diagnostic toward clinical validation and commercialization. Kalyuzhny joins Aqtual as the company expands development of its active chromatin cell-free DNA (cfDNA) platform, which is designed to support therapy selection, biomarker discovery, and drug development. In his new role, he will oversee financial strategy, capital formation, and strategic transactions while helping guide the company's commercial and partnership initiatives. The appointment comes as Aqtual seeks to broaden the application of its functional liquid biopsy platform through biopharmaceutical collaborations, co-development programs, and licensing opportunities while continuing to build its proprietary biobank to support future research and data-driven partnerships. "The opportunity in front of Aqtual has expanded, and this is the right time to add Daniil's perspective to the team," said founder and Chief Executive Officer Diana Abdueva. "He brings the sector judgment and transaction experience to help us set priorities, make the right calls and execute." Before joining Aqtual, Kalyuzhny served as managing director in the Global Healthcare Group at BTIG, where he led investment banking coverage for diagnostics and life sciences tools companies. During his tenure, he advised executive teams and boards on mergers and acquisitions, capital raises, and strategic partnerships, working on transactions with an aggregate value exceeding $25 billion. His experience spans financial strategy and corporate development for companies operating across the precision medicine, diagnostics, and life sciences sectors, providing expertise that Aqtual expects to leverage as it advances both its clinical programs and commercialization strategy. "One of the defining challenges for platform companies is deciding where to invest, where to partner and how to allocate capital across multiple opportunities," Kalyuzhny said. "Aqtual has built an exceptional scientific foundation with multiple paths to creating long-term value. I'm excited to join the team and help build the financial strategy that supports the company's long-term vision." The appointment reflects a common trend among emerging biotechnology companies preparing for commercialization and strategic expansion. As platform technology companies move beyond research and early development, they often recruit executives with investment banking and transaction experience to support fundraising, business development, licensing, and potential strategic partnerships. Aqtual is developing a proprietary liquid biopsy platform that analyzes active chromatin cell-free DNA to evaluate protein regulation, epigenetic activity, and transcriptomic signals using blood samples. The technology is intended to provide real-time insights into disease biology and treatment response while addressing limitations associated with conventional cell-free DNA testing approaches. The company is advancing its first therapy-selection diagnostic through clinical validation while expanding applications of its platform in oncology and chronic disease management. In parallel, Aqtual continues to grow its proprietary biobank, which it views as a strategic asset for biomarker discovery, pharmaceutical collaborations, and future precision medicine applications. Kalyuzhny's appointment positions the company to support these initiatives with a financial strategy focused on capital allocation, partnership development, and long-term growth.

BTIG

Healthcare Investment Banking Managing Director - Equity Capital Markets, Healthcare

About the job